These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3553811)

  • 1. Host-pathogen interaction--new in vitro drug test systems against Mycobacterium leprae--possibilities and limitations.
    Mahadevan PR; Jagannathan R; Bhagaria A; Vejare S; Agarwal S
    Lepr Rev; 1986; 57 Suppl 3():182-200. PubMed ID: 3553811
    [No Abstract]   [Full Text] [Related]  

  • 2. The activity of rifabutin against Mycobacterium leprae in armadillos.
    Dhople AM; Williams SL
    Int J Antimicrob Agents; 1997 Jan; 9(3):169-73. PubMed ID: 9552713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited in vitro multiplication of Mycobacterium leprae: application to screening potential antileprosy compounds.
    Dhople AM; Green KJ
    Lepr Rev; 1986; 57 Suppl 3():149-62. PubMed ID: 3553808
    [No Abstract]   [Full Text] [Related]  

  • 4. The "proportional bactericidal test": a method for assessing bactericidal activity in drugs against Mycobacterium leprae in mice.
    Colston MJ; Hilson GR; Banerjee DK
    Lepr Rev; 1978 Mar; 49(1):7-15. PubMed ID: 347206
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism in Mycobacterium leprae: possible targets for drug action.
    Wheeler PR
    Lepr Rev; 1986; 57 Suppl 3():171-81. PubMed ID: 3553810
    [No Abstract]   [Full Text] [Related]  

  • 6. Single bacterial cell mass analysis: a rapid test method in leprosy therapy control.
    Seydel U; Lindner B
    Lepr Rev; 1986; 57 Suppl 3():163-70. PubMed ID: 3553809
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
    Dhople AM; Dimova V
    Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
    Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM
    Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug effects on intracellular mycobacteria determined by mass spectrometric analysis of the Na(+)-to-K+ ratios of individual bacterial organisms.
    Wiese M; Seydel U
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2047-53. PubMed ID: 8878579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activities of macrolides against Mycobacterium leprae.
    Franzblau SG; Hastings RC
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1758-62. PubMed ID: 3072920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):96-101. PubMed ID: 7042616
    [No Abstract]   [Full Text] [Related]  

  • 13. In-vitro activity of three new fluoroquinolones and synergy with ansamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA
    J Antimicrob Chemother; 1993 Sep; 32(3):445-51. PubMed ID: 8262866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of sitafloxacin (DU-6859a), either singly or in combination with rifampin analogs, against Mycobacterium leprae.
    Dhople AM; Namba K
    J Infect Chemother; 2003 Mar; 9(1):12-5. PubMed ID: 12673400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of in vitro Fc receptor assay with in vivo mouse foot pad method.
    Jagannathan R; Patil D; Mahadevan PR
    Indian J Lepr; 1988 Oct; 60(4):517-25. PubMed ID: 3075631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of resistance to rifampicin in Mycobacterium leprae.
    Roche PW; Shrestha N; Thomas A; Honore N; Cole ST
    Lepr Rev; 2000 Dec; 71 Suppl():S96-7; discussion S97-9. PubMed ID: 11201897
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of hypoxanthine incorporation in purified suspensions of Mycobacterium leprae: a suitable method to screen for anti-leprosy agents in vitro.
    Wheeler PR
    J Med Microbiol; 1988 Mar; 25(3):167-74. PubMed ID: 3279214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeling of Mycobacterium leprae lipids within schwannoma cells, a potential drug screening system.
    Mistry Y; Antia NH; Mukherjee R
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1444-7. PubMed ID: 1929306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A series of new antileprosy compounds derived from serotonin.
    Mester de Parajd L; Rees RJ; Ambrose EJ; Mester de Parajd M
    Acta Leprol; 1985; 3(1):21-8. PubMed ID: 3927649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.